Company Filing History:
Years Active: 1985-1989
Title: Innovations of Wolfgang G. Dippold in Cancer Research
Introduction
Wolfgang G. Dippold is a notable inventor in the field of cancer research, particularly recognized for his contributions to the development of monoclonal antibodies. Based in Mainz, Germany, he has been instrumental in advancing the understanding and detection of human melanoma cells through innovative methodologies.
Latest Patents
Dippold holds two significant patents that highlight his expertise. The first patent focuses on monoclonal antibodies to cell surface antigens of human malignant cells, specifically targeting human melanoma cells. This patent outlines a method of production and use for these antibodies, which have shown promise in cancer diagnostics. The second patent details a method for detecting the presence of G.sub.D3 ganglioside, utilizing the mouse monoclonal antibody AbR.sub.24. This antibody exhibits a high degree of specificity for human melanoma cells, as demonstrated through various assays, including the PA-MHA serological assay. The research indicates that G.sub.D3 ganglioside is a critical component in melanoma cells, providing a pathway for targeted cancer therapies.
Career Highlights
Dippold's career is marked by his association with the Sloan-Kettering Institute for Cancer Research, where he has contributed significantly to the field of oncology. His work has not only advanced scientific knowledge but has also paved the way for potential therapeutic applications in cancer treatment.
Collaborations
Throughout his career, Dippold has collaborated with esteemed colleagues, including Kenneth O. Lloyd and Herbert F. Oettgen. These collaborations have further enriched his research and expanded the impact of his innovations in cancer research.
Conclusion
Wolfgang G. Dippold's contributions to the field of cancer research through his patents and collaborations underscore his role as a leading inventor in the development of diagnostic tools for melanoma. His work continues to influence the landscape of cancer diagnostics and treatment.